Literature DB >> 1318323

Molecular basis of age-dependent gastric inactivation of rhesus rotavirus in the mouse.

D M Bass1, M Baylor, R Broome, H B Greenberg.   

Abstract

Rotavirus requires specific proteolytic activation by trypsin for efficient replication in tissue culture. To observe the nature of intestinal proteolytic activation of rotavirus in vivo, metabolically labeled rhesus rotavirus (RRV) grown in the presence of trypsin inhibitors was administered to adult and 10-d-old suckling mice by gavage. In the adult stomach, vp4 was cleaved in a manner distinct from in vitro trypsin cleavage. In the suckling stomach, RRV vp4 remains largely uncleaved. The alternative cleavage in the adult stomach was associated with a profound decrease in viral infectivity. vp4 from RRV recovered from the suckling small intestinal lumen was cleaved in a pattern similar or identical to in vitro trypsin-activated virus with bands comigrating with vp5* and vp8*. In contrast, vp4 was not observed in any recognizable form in RRV recovered from adult intestines. Comparison of infectivity of virus recovered from suckling and adult intestines revealed a 10,000-fold decrease in titer in the virus recovered from the adult intestine. In vitro digestions of RRV revealed that pepsin digestion can cleave RRV vp4 and markedly enhance acid-induced loss of rotavirus infectivity. Subsequent digestion with chymotrypsin removes most of the pepsin cleavage products of vp4. Virus injected directly into jejunal loops of adult mice and virus administered orally to adult mice pretreated with antiacid drugs retained infectivity. These studies indicate the development of gastric acid and pepsin secretion may be an important host defense factor in rotavirus gastroenteritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318323      PMCID: PMC295862          DOI: 10.1172/JCI115776

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Intraluminal proteolytic activation plays an important role in replication of type 1 reovirus in the intestines of neonatal mice.

Authors:  D M Bass; D Bodkin; R Dambrauskas; J S Trier; B N Fields; J L Wolf
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

2.  Failure in chymotrypsin enhancement of human rotavirus infectivity.

Authors:  S Kitaoka; H Suzuki; T Sato; Y Numazaki; T Konno; N Ishida
Journal:  Tohoku J Exp Med       Date:  1987-01       Impact factor: 1.848

3.  Minimal infective dose of rotavirus.

Authors:  D Y Graham; G R Dufour; M K Estes
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Increased "take" rate of oral rotavirus vaccine in infants after milk feeding.

Authors:  T Vesikari; E Isolauri; E D'Hondt; A Delem; F E André
Journal:  Lancet       Date:  1984-09-22       Impact factor: 79.321

5.  Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis.

Authors:  K T Kaljot; R D Shaw; D H Rubin; H B Greenberg
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

6.  Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice.

Authors:  D K Bodkin; M L Nibert; B N Fields
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  Conservation of amino acid sequence of VP8 and cleavage region of 84-kDa outer capsid protein among rotaviruses recovered from asymptomatic neonatal infection.

Authors:  M Gorziglia; Y Hoshino; A Buckler-White; I Blumentals; R Glass; J Flores; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

8.  NS35 and not vp7 is the soluble rotavirus protein which binds to target cells.

Authors:  D M Bass; E R Mackow; H B Greenberg
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

9.  Protease inhibitors suppress the in vitro and in vivo replication of rotavirus.

Authors:  S L Vonderfecht; R L Miskuff; S B Wee; S Sato; R R Tidwell; J D Geratz; R H Yolken
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

10.  Plaque assay of neonatal calf diarrhea virus and the neutralizing antibody in human sera.

Authors:  S Matsuno; S Inouye; R Kono
Journal:  J Clin Microbiol       Date:  1977-01       Impact factor: 5.948

View more
  7 in total

1.  Validation of the blood quininium resin test for assessing gastric hypochlorhydria.

Authors:  Catherine De Martel; Sarah Ratanasopa; Douglas Passaro; Julie Parsonnet
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

Review 2.  Rotavirus infection.

Authors:  Sue E Crawford; Sasirekha Ramani; Jacqueline E Tate; Umesh D Parashar; Lennart Svensson; Marie Hagbom; Manuel A Franco; Harry B Greenberg; Miguel O'Ryan; Gagandeep Kang; Ulrich Desselberger; Mary K Estes
Journal:  Nat Rev Dis Primers       Date:  2017-11-09       Impact factor: 52.329

3.  Liposome-mediated transfection of intact viral particles reveals that plasma membrane penetration determines permissivity of tissue culture cells to rotavirus.

Authors:  D M Bass; M R Baylor; C Chen; E M Mackow; M Bremont; H B Greenberg
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

4.  Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence.

Authors:  R L Broome; P T Vo; R L Ward; H F Clark; H B Greenberg
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

5.  Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity.

Authors:  Rebecca J Gorrell; Roy M Robins-Browne
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

6.  Gastroduodenal Perforation and Ulcer Associated With Rotavirus and Norovirus Infections in Japanese Children: A Case Report and Comprehensive Literature Review.

Authors:  Norishi Ueda
Journal:  Open Forum Infect Dis       Date:  2016-02-09       Impact factor: 3.835

7.  In vitro antiviral activity against rotavirus and astrovirus infection exerted by substances obtained from Achyrocline bogotensis (Kunth) DC. (Compositae).

Authors:  M A Téllez; A N Téllez; F Vélez; J C Ulloa
Journal:  BMC Complement Altern Med       Date:  2015-12-03       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.